Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer/BioNTech's COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows

According to a published study, Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) two-dose COVID-19 vaccine provided very little protection for children aged 5 to 11 years during the wave of o

Benzinga

Pfizer's Clostridioides Difficile Vaccine Fails To Prevent C. Difficile Infection

Pfizer Inc (NYSE: PFE) announced data from the CLOVER Phase 3 trial evaluating Clostridioides difficile vaccine candidate to prevent C. difficile infection (CDI).

Benzinga

COVID vax: Pregnant women left behind

Clinical trials of COVID vaccines excluded pregnant people, which left many wondering whether to get vaccinated

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

A South African company addresses vaccine supply inequity, despite Canada's lack of support

Since late 2020, the inequitable access across the globe to COVID-19 vaccines has been a glaring problem. But a remarkable achievement earlier this month offers hope that the supply of vaccines to developing countries will improve: Afrigen Biologics, a South African based company, produced its own version of Moderna’s mRNA…

The Conversation

Pfizer vaccine significantly less effective in children ages five to 11, study shows

Strikingly higher rates of decline in effectiveness for younger children suggest the lower dose they receive may be the reason

The Guardian - US

Pfizer vaccine much less successful at preventing Covid infections in young children, data shows

‘In the Omicron era, the effectiveness against cases of BNT162b2 declined rapidly for children, particularly those 5-11 years,’ a new study says

The Independent UK

What Are Whales Doing With Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 29 strange trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Drugmakers Reap Billions Meeting Covid-19 Needs

Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.

Bangkok Post

Covid vaccines for children: how many doses are needed and what happens if they’ve been infected or are under five?

Making sure adults and older children are vaccinated, as well as mask wearing and social distancing, is the best thing to do if worried about under-fives not being eligible, expert says

The Guardian - AU

Q&A: Why the CDC suggests more time between 1st and 2nd COVID vaccine doses for some people

LOS ANGELES — After recommending for more than a year that people wait only a few weeks between their first and second doses of COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention has adjusted its suggested timeline for some people by another month or so.

Los Angeles Times

Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests

The Centers for Disease Control and Prevention said that younger males should consider waiting longer between doses of Pfizer Inc's (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) and Moderna

Benzinga

Pan corona vax in the works: mRNA scientist Drew Weissman

HYDERABAD: At a time when there are fears of the emergence of new Covid-19 variants, American physician-scientist Dr Drew Weissman, who along with Dr Katalin Kariko worked on the mRNA vaccine platform that enabled Pfizer and Moderna to develop Covid-19 vaccines, said his lab was now working on a pan…

The Times of India

Pfizer Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 45 strange trades.

Benzinga

Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Wednesday financial results for the fourth quarter and full year ended Dec. 31, 2021. Q4 Finanical HIghlights

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Will you need a 2nd booster shot to keep coronavirus at bay?

With omicron fading and pressure growing to ease mask rules and other pandemic restrictions, there is growing debate among health officials and experts about if or when a second booster shot will be part of this path toward recovery.

The Independent UK

CDC: Some people should wait longer for 2nd COVID shot

U.S. health officials say some people getting Pfizer or Moderna COVID-19 vaccines should consider waiting up to eight weeks between the first and second doses

The Guardian - UK

Covid live: Poland, Slovakia and Iceland latest countries set to end most coronavirus restrictions — as it happened

Move comes as case numbers and deaths continue to fall in many nations

The Conversation

The Moderna vaccine is now available for 6 to 11 year olds. Here's what parents need to know

Australian children aged six to 11 years old will be able to get the Moderna COVID vaccine at pharmacies, GP clinics and vaccination hubs from tomorrow.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

S. Korea approves Pfizer's COVID vaccine for ages 5-11

South Korean health officials have approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country's immunization program in the face of a massive omicron outbreak that is driving up hospitalizations and deaths

ABC News

Moderna COVID-19 vaccine approved for six- to 11-year-old children

Children aged six to 11 years can get a Moderna COVID-19 vaccine from tomorrow, after it was given the final green light.

The Conversation

Do COVID boosters cause more or fewer side effects? How quickly does protection wane? Your questions answered

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends Australians aged 16 years and older have a COVID booster vaccine three months after receiving their second dose.

Tribune News Service

Mayo Clinic expert stresses importance of vaccinating school-age children for COVID-19

Parents hoping to get their young children vaccinated for COVID-19 will have to wait at least another two months. The Food and Drug Administration (FDA) recently postponed a decision on an emergency use authorization of the Pfizer vaccine for kids 6 months to 4 years old. The FDA is waiting…

The Guardian - UK

Germany to begin rollout of Novavax’s jab; New Zealand to end vaccine mandates after Omicron peak

Latest updates: Germany hopes protein-based vaccine comparable to flu jabs will help sway people sceptical of mRNA vaccines

Asharq Al-Awsat

Egypt to Receive New Batches of Pfizer Covid Vaccines

Health Ministry Spokesman Hossam Abdel Ghaffar said Egypt is set to receive a new shipment containing 2,158,650 doses of the Pfizer coronavirus vaccine. In statements to the MENA news agency on Saturday, the spokesman added that the shipment is part of the state’s plan to provide various kinds of vaccines…

Ballotpedia

The Federal Tap: Congressman Jim Hagedorn (R) passes away

Our weekly summary of federal news updates you on Congressman Jim Hagedorn’s (R) recent death and the newest congressional districts in Minnesota. Read all about it in this week’s edition of the Federal Tap.

1 … 65 66 67 68

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Food and Drug Administration

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.